|
Mr. Fishebein has over 25 years of experience in pharmaceutical and biotech marketing, commercial development and life cycle management. Prior to joining Aton, he was a life science consultant for Strategyx. Prior to this assignment Mr. Fishebein was the Vice President of Marketing and Corporate Product Planning at Savient where he was integral to establishing the company’s initial commercial infrastructure. Mr. Fishbein re-launched the company’s sole commercial product, maintaining its viability for over a decade. Prior to Savient, he was Director of Market Planning for Wyeth, responsible for their Injectible Pharmaceuticals Division. Prior to Wyeth, Mr. Fishebein held marketing and market research positions for new and in-line products at Genentech and the McNeil Pharmaceutical division of Johnson & Johnson. Before McNeil, he established the GlaxoSmithKline’s Reference Lab Business, which became the number one lab, and is now known as Quest Diagnostics. He holds a BA degree in Economics from George Washington University and a MBA from The Wharton School. | 